EDGAR Filing Documents for 0001144204-13-035063

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001144204-13-035063

Filing Date

2013-06-14

Accepted

2013-06-14 17:25:42

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 1 TO FORM S-1	v347767_s1a.htm	S-1/A	848849
2	EXHIBIT 1.1	v347767_ex1-1.htm	EX-1.1	219397
3	EXHIBIT 5.1	v347767_ex5-1.htm	EX-5.1	10906
4	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	v347767_ex23x1.htm	EX-23.1	3020
5	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	v347767_ex23x2.htm	EX-23.2	2513
6	GRAPHIC	logo_mintzlevin.jpg	GRAPHIC	3108
7	GRAPHIC	line.gif	GRAPHIC	43
8	GRAPHIC	spacer.gif	GRAPHIC	43
9	GRAPHIC	logo_intercept.jpg	GRAPHIC	7815
10	GRAPHIC	v347345_chrt-bar.jpg	GRAPHIC	20130
11	GRAPHIC	v347345_chrt-line1.jpg	GRAPHIC	12810
12	GRAPHIC	v347345_chrt-line2.jpg	GRAPHIC	12561
13	GRAPHIC	v347345_chrt-line3.jpg	GRAPHIC	11261
	Complete submission text file	0001144204-13-035063.txt		1180210

Mailing Address 18 Desbrosses Street New York NY 10013

Business Address 18 Desbrosses Street NEW YORK NY 10013 646-747-1000

INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)